bell
The current prices are delayed by 15 mins, login to check live prices.
Kobo Biotech Ltd share price logo

Kobo Biotech Ltd

(531541)

₹2.713.21%

as on 04:01PM, 22 Nov 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Kobo Biotech Ltd Performance

  • Day's Low

    Day's High

    ₹2.68
    ₹2.8
  • 52 Week's Low

    52 Week's High

    ₹2.66
    ₹6.01
1 Month Return-2.49 %
3 Month Return-12.46 %
1 Year Return-8.05 %
Previous Close₹2.80
Open₹2.72
Volume27.31K
Upper Circuit-
Lower Circuit-
Market Cap₹6.67Cr

Kobo Biotech Ltd Key Statistics

P/E Ratio0
PEG Ratio0
Market Cap₹6.67 Cr
P/B Ratio-0.04
EPS0
Dividend Yield0
SectorPharmaceuticals
ROE0

Kobo Biotech Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹6.67 Cr20%5.69NANA
NA₹44.02 Cr1.53%0.58NANA
NA₹260.52 Cr273.93%0.58-₹12 Cr₹15 Cr
NA₹286.75 Cr122.28%0.66₹5 Cr₹155 Cr
NA₹15,763.63 Cr26.32%0.51NANA

About Kobo Biotech Ltd

Avon Organics, a company set-up by P.R. Agarwal Rajesh Agarwal and G.S. Sidhu and incorporated in August 1993, specializes in manufacturing diketene & its derivatives like Monomethyl Acetoncetamide (MMA) and Methyl Acetoacetate (MAA). The company’s 1200 TPA Diketene manufacturing facility is based in Andhra Pradesh and its products have application in pigments, pharmaceuticals and pesticides. The company has technical knowhow agreement agreements in place with Shanghai Machinery & Equipment Import & Export Corporation, Xytel Technologies Partnership USA and Shanghai Peng Pu Chemical works. It has also been awarded Best New Product manufactured in the State of Andhra Pradesh by the Federation of Andhra Pradesh Chamber of Commerce and Industry and certified ISO 9002 by ANSIRAB. In addition to this, Avon Organics is also involved in Biotechnology and has a plant in Solapur, Maharashtra with an installed capacity of 150 MT. It has signed long term export contracts of Pseudoephedrine, gotten FDA approval and is about to introduce two new high value added intermediates in its Diketene division. All said, it is expected to add an additional turnover of Rs. 12 crores in 200506.

Share Price: ₹2.71 per share as on 22 Nov, 2024 04:01 PM
Market Capitalisation: ₹6.67Cr as of today
Chairperson Name: Ajit Kamath
OrganisationKobo Biotech Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Kobo Biotech Ltd

  • Kobo Biotech Q3 FY24 Results Declared - 17 Feb, 2024

    Kobo Biotech Ltd has declared their Q3 FY24 results, with a 0% decrease in topline and a 3.38% YoY increase in loss. The EPS for Q3 FY24 is ₹-0.52, which decreased by 4% YoY. Kobo Biotech delivered -5.62% return in the last week, 60.31% return in the last 6 months, and 68.06% YTD return.

Insights on Kobo Biotech Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 62.6% return, outperforming this stock by 70.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 128.6% return, outperforming this stock by 169.7%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 54.39% of holdings in Mar 2024 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 44.95% of holdings in Mar 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, Kobo Biotech stock has moved down by -41.1%

Kobo Biotech Ltd Financials

Value in ₹ crore
Details2020202120222023
Total Assets₹236.33Cr (-)₹230.59Cr (↓2.43%)₹79.19Cr (↓65.66%)₹75.33Cr (↓4.87%)
Total Liabilities₹324.30Cr (-)₹337.79Cr (↑4.16%)₹201.61Cr (↓40.31%)₹203.31Cr (↑0.84%)
Value in ₹ crore
Details20192020202120222023
Operating Cash Flow₹20.95Cr (-)₹14.48Cr (↓30.88%)₹2.51Cr (↓82.67%)₹93.76Cr (↑3,635.46%)₹0.87Cr (↓99.07%)
0

Kobo Biotech Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
44.95%
0.00
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
54.39%
0.00
Others
0.66%
0.00

Kobo Biotech Ltd Key Indicators

Details20122013
Earning Per Share (₹)6.86.07
Details201220132014
Book Value Per Share (₹)32.8439.0623.59

Kobo Biotech Ltd Earnings and Dividends

  • Kobo Biotech Ltd Earnings Results

    Kobo Biotech Ltd’s net profit fell -8.13% since last year same period to ₹-1.33Cr in the Q1 2024-2025. On a quarterly growth basis, Kobo Biotech Ltd has generated -5.56% fall in its net profits since last 3-months.

    Read More about Earnings Results

Kobo Biotech Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Kobo Biotech Ltd is currently in a Bearish trading position according to technical analysis indicators.

FAQs on Kobo Biotech Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Kobo Biotech Ltd shares.

Kobo Biotech Ltd (531541) share price today is ₹2.71

Kobo Biotech Ltd is not listed on NSE

Kobo Biotech Ltd is listed on BSE

  • Today’s highest price of Kobo Biotech Ltd is ₹2.8.
  • Today’s lowest price of Kobo Biotech Ltd is ₹2.68.

Today’s traded volume of Kobo Biotech Ltd(531541) is 27.31K.

Today’s market capitalisation of Kobo Biotech Ltd(531541) is ₹6.67Cr.

Kobo Biotech Ltd(531541Price
52 Week High
₹6.01
52 Week Low
₹2.66

Kobo Biotech Ltd(531541) share price is ₹2.71. It is down -54.91% from its 52 Week High price of ₹6.01

Kobo Biotech Ltd(531541) share price is ₹2.71. It is up 1.88% from its 52 Week Low price of ₹2.66

Kobo Biotech Ltd(531541Returns
1 Day Returns
-0.09%
1 Month Returns
-2.49%
3 Month Returns
-12.46%
1 Year Returns
-8.05%